XML 60 R49.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Share-based Compensation Arrangement By Share-based Payment Award, Options and Stock Appreciation Rights, Outstanding [Roll Forward]          
Grants in Period (in shares) 0 0 262,091 213,618  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 48.32    
Exercises in Period (in shares)     182,487    
Weighted Average Exercise Price, Exercises in Period (in dollars per share)     $ 33.57    
Forfeitures in Period (in shares)     39,112    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share)     $ 65.57    
Weighted Average Remaining Contractual Term, Outstanding (in years)     5 years 8 months 12 days    
Weighted Average Remaining Contractual Term, Exercisable (in years)     5 years    
Aggregate Intrinsic Value, Outstanding $ 679   $ 679    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 679   $ 679    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,377,541   2,377,541   2,337,049
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 60.37   $ 60.37   $ 59.72
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,844,929   1,844,929    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 62.32   $ 62.32